Cleared Traditional

K063107 - 3DNET SUITE

K063107 is an FDA 510(k) clearance for 3DNET SUITE, manufactured by Biotronics3D, Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 16-day FDA review.

K063107 · Biotronics3D, Ltd. · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2006
Decision
16d
Days
Class 2
Risk

K063107 is an FDA 510(k) clearance for the 3DNET SUITE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Biotronics3D, Ltd. (London, GB). The FDA issued a Cleared decision on October 27, 2006 after a review of 16 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K063107

510(k) Number K063107 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 11, 2006
Decision Date October 27, 2006
Days to Decision 16 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 107d · This submission: 16d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Kema Quality B.V.
PATRICIA L MURPHY

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2282
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K063107.
VISTADENT OC - VERSION 4
K060836 · Dentsply Intl., Inc. · Oct 2006
AMICAS VISION SERIES PACS, MODEL 4.3
K062477 · Amicas, Inc. · Oct 2006
VISAGE PACS/CS, RELEASE VERSION 4.1
K062490 · Mercury Computer Systems, Inc. · Oct 2006
CENTARISONE RIS/PACS
K063037 · Centarisone, LLC · Oct 2006
5 MEGAPIXEL MONOCHROME LCD MONITOR, RADIFORCE GS510
K062054 · Eizo Nanao Corporation · Oct 2006
CHASE CARDIAC ANALYSIS SYSTEM
K062031 · Chase Medical, LP · Sep 2006
K063107 · 3DNET SUITE
Download PDF FDA Summary Biotronics3D, Ltd.